Zacks: Brokerages Expect Henry Schein, Inc. (NASDAQ:HSIC) Will Announce Earnings of $0.93 Per Share

Wall Street analysts forecast that Henry Schein, Inc. (NASDAQ:HSIC) will post earnings of $0.93 per share for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for Henry Schein’s earnings, with the lowest EPS estimate coming in at $0.88 and the highest estimate coming in at $1.00. Henry Schein posted earnings per share of $1.03 during the same quarter last year, which indicates a negative year-over-year growth rate of 9.7%. The business is expected to report its next quarterly earnings report on Monday, November 1st.

On average, analysts expect that Henry Schein will report full year earnings of $4.31 per share for the current fiscal year, with EPS estimates ranging from $4.23 to $4.41. For the next financial year, analysts anticipate that the firm will post earnings of $4.58 per share, with EPS estimates ranging from $4.38 to $4.89. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that that provide coverage for Henry Schein.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 3rd. The company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.13. Henry Schein had a net margin of 5.09% and a return on equity of 15.86%. The business had revenue of $2.97 billion during the quarter, compared to analyst estimates of $2.87 billion. Henry Schein’s revenue was up 76.2% on a year-over-year basis.

A number of research firms have recently weighed in on HSIC. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating and set a $82.00 target price for the company. in a report on Tuesday, October 5th. Barrington Research raised their price target on shares of Henry Schein from $91.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, August 4th. Finally, Piper Sandler lifted their target price on shares of Henry Schein from $89.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 3rd. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $90.50.

NASDAQ HSIC opened at $77.72 on Thursday. The company has a 50-day simple moving average of $77.20 and a two-hundred day simple moving average of $76.15. The company has a quick ratio of 0.98, a current ratio of 1.79 and a debt-to-equity ratio of 0.18. Henry Schein has a 12-month low of $59.44 and a 12-month high of $83.45. The firm has a market cap of $10.86 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.32 and a beta of 0.88.

Institutional investors have recently bought and sold shares of the company. JLB & Associates Inc. increased its holdings in shares of Henry Schein by 1.6% in the 2nd quarter. JLB & Associates Inc. now owns 88,584 shares of the company’s stock worth $6,572,000 after buying an additional 1,401 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in Henry Schein by 70.9% during the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 17,105 shares of the company’s stock valued at $1,269,000 after purchasing an additional 7,095 shares during the last quarter. Stephens Investment Management Group LLC grew its holdings in Henry Schein by 8.5% during the 1st quarter. Stephens Investment Management Group LLC now owns 76,827 shares of the company’s stock valued at $5,320,000 after purchasing an additional 6,011 shares during the last quarter. Lodge Hill Capital LLC bought a new position in Henry Schein during the 2nd quarter valued at about $14,096,000. Finally, Voloridge Investment Management LLC grew its holdings in Henry Schein by 21.1% during the 1st quarter. Voloridge Investment Management LLC now owns 94,449 shares of the company’s stock valued at $6,540,000 after purchasing an additional 16,473 shares during the last quarter. Hedge funds and other institutional investors own 93.16% of the company’s stock.

About Henry Schein

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Read More: Find a Trading Strategy That Works

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.